echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Diabetologia: Type 1 Diabetes Cardiovascular Health Indicator May Predict Cardiovascular Events

    Diabetologia: Type 1 Diabetes Cardiovascular Health Indicator May Predict Cardiovascular Events

    • Last Update: 2022-05-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Background: Cardiovascular disease (CVD), such as myocardial infarction and stroke, is one of the most important complications of diabetes


    Background: Cardiovascular disease (CVD), such as myocardial infarction and stroke, is one of the most important complications of diabetes


    The American Heart Association (AHA) publishes the criteria for ideal cardiovascular health, identifying seven indicators: smoking, BMI, physical activity, diet, total cholesterol, blood pressure, and fasting blood sugar


    The first study of desirable health indicators by Alman et al.


    OBJECTIVE: The purpose of this prospective study was to examine (1) a population with favorable measures of cardiovascular health and (2) classification of these measures to reduce cardiovascular risk in patients with type 1 diabetes


    METHODS: Data from 2313 subjects enrolled in the EURODIAB Prospective Complications Study were analyzed


    RESULTS: During a mean (7.


    Figure 1 Rates of cardiovascular events (95% CI), adjusted for age and sex at diabetes diagnosis based on the number of most favorable cardiovascular health indicator groups or tertiles in the model for input data: EURODIAB Prospective Complications Research

    Figure 1 Rates of cardiovascular events (95% CI), adjusted for age and sex at diabetes diagnosis based on the number of most favorable cardiovascular health indicator groups or tertiles in the model for input data: EURODIAB Prospective Complications Research

    Table 1 Baseline characteristics of participants in the EURODIAB study of patients with type 1 diabetes, by cardiovascular disease status

    Table 1 Baseline characteristics of participants in the EURODIAB study of patients with type 1 diabetes, by cardiovascular disease status

    Conclusions: In our study, low HbA1c and hypotension were protective indicators of cardiovascular health in patients with type 1 diabetes


    Conclusions: In our study, low HbA1c and hypotension were protective indicators of cardiovascular health in patients with type 1 diabetes


    Original source: Soulimane S, Balkau B, Vogtschmidt YD, et al.
    Incident cardiovascular disease by clustering of favourable risk factors in type 1 diabetes: the EURODIAB Prospective Complications Study.
    Diabetologia 2022 Apr 12 Incident cardiovascular disease by clustering of favourable risk factors in type 1 diabetes: the EURODIAB Prospective Complications Study.


    Leave a comment here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.